Next-generation sequencing of lung cancer EGFR exons 18-21 allows effective molecular diagnosis of small routine samples (cytology and biopsy).

MLA

Dario de Biase, et al. “Next-Generation Sequencing of Lung Cancer EGFR Exons 18-21 Allows Effective Molecular Diagnosis of Small Routine Samples (Cytology and Biopsy).” PLoS ONE, vol. 8, no. 12, Jan. 2013, p. e83607. EBSCOhost, https://doi.org/10.1371/journal.pone.0083607.

APA

Dario de Biase, Michela Visani, Umberto Malapelle, Francesca Simonato, Valentina Cesari, Claudio Bellevicine, Annalisa Pession, Giancarlo Troncone, Ambrogio Fassina, & Giovanni Tallini. (2013). Next-generation sequencing of lung cancer EGFR exons 18-21 allows effective molecular diagnosis of small routine samples (cytology and biopsy). PLoS ONE, 8(12), e83607. https://doi.org/10.1371/journal.pone.0083607

Chicago

Dario de Biase, Michela Visani, Umberto Malapelle, Francesca Simonato, Valentina Cesari, Claudio Bellevicine, Annalisa Pession, Giancarlo Troncone, Ambrogio Fassina, and Giovanni Tallini. 2013. “Next-Generation Sequencing of Lung Cancer EGFR Exons 18-21 Allows Effective Molecular Diagnosis of Small Routine Samples (Cytology and Biopsy).” PLoS ONE 8 (12): e83607. doi:10.1371/journal.pone.0083607.